NASDAQ:ICCC

Immucell Stock News

Healthcare > Biotechnology

Buy ICCC

*Your capital is at risk

$11.21

+0.150 (+1.36%)

At Close: Jul 31, 2026

45 Biggest Movers From Yesterday

12:00am, Wednesday, 20'th Dec 2017

ImmuCell Prices its $3M Offering at $7.30/Share

12:00am, Tuesday, 19'th Dec 2017

ImmuCell Reports Q3 EPS $(0.07) vs. $0.01 In Same Qtr. Last Year, Sales $2M vs. $2M YoY

12:00am, Monday, 13'th Nov 2017

ImmuCell to Announce Financial Results for Third Quarter of —…–7

12:00am, Thursday, 02'nd Nov 2017

Immucell Expects to Achieve Regulatory Approval for First Defense Tri-Shield in Q4 2017

12:00am, Wednesday, 13'th Sep 2017

18 Biggest Mid-Day Losers For Tuesday

12:00am, Tuesday, 15'th Aug 2017

ImmuCell Reports Q2 EPS $(0.05) vs $(0.01) In Same Qtr. Last Year, Sales $1.75M vs $2.4M YoY

12:00am, Monday, 14'th Aug 2017

ImmuCell's (ICCC) CEO Michael Brigham on Q4 2016 Results - Earnings Call Transcript

12:00am, Friday, 10'th Feb 2017

ImmuCell Reports Prelim. Q4 EPS $0.01 vs. Prior Year Quarter $0.09, Rev. $2.2M vs. Prior Year Quarter $2.69M

12:00am, Thursday, 09'th Feb 2017

ImmuCell's (ICCC) CEO Michael Brigham on Q3 2016 Results - Earnings Call Transcript

12:00am, Friday, 11'th Nov 2016

ImmuCell Reports Q3 EPS $0.01, Sales $1.968M

12:00am, Thursday, 10'th Nov 2016

ImmuCell Reports Raising of $3.5M Through Private Placement

12:00am, Tuesday, 18'th Oct 2016

ImmuCell Breaks Ground for Mast Out(R) Facility Reports Contract With Consigli Amended At ~$11M in Q4

12:00am, Tuesday, 11'th Oct 2016

Immucell Stock News

45 Biggest Movers From Yesterday

ImmuCell Prices its $3M Offering at $7.30/Share

ImmuCell Reports Q3 EPS $(0.07) vs. $0.01 In Same Qtr. Last Year, Sales $2M vs. $2M YoY

ImmuCell to Announce Financial Results for Third Quarter of —…–7

Immucell Expects to Achieve Regulatory Approval for First Defense Tri-Shield in Q4 2017

18 Biggest Mid-Day Losers For Tuesday

ImmuCell Reports Q2 EPS $(0.05) vs $(0.01) In Same Qtr. Last Year, Sales $1.75M vs $2.4M YoY

ImmuCell's (ICCC) CEO Michael Brigham on Q4 2016 Results - Earnings Call Transcript

ImmuCell Reports Prelim. Q4 EPS $0.01 vs. Prior Year Quarter $0.09, Rev. $2.2M vs. Prior Year Quarter $2.69M

ImmuCell's (ICCC) CEO Michael Brigham on Q3 2016 Results - Earnings Call Transcript

ImmuCell Reports Q3 EPS $0.01, Sales $1.968M

ImmuCell Reports Raising of $3.5M Through Private Placement

ImmuCell Breaks Ground for Mast Out(R) Facility Reports Contract With Consigli Amended At ~$11M in Q4

ImmuCell Corp. Reports Q2 EPS Breakeven vs. Prior Year Quarter $0.03, Rev. $2.4M

ImmuCell Corporation: A Cheap Biotech With Upcoming FDA Approval Catalyst

Top Fintech Company